MMTX.SW MindMaze Therapeutics (SIX) down 10.21% to CHF0.77 on 25 Feb 2026: oversold, watch support

MMTX.SW stock opened at CHF0.90 and traded down to CHF0.72 intraday, closing the session around CHF0.77, a -10.21% move on 25 Feb 2026. This sharp drop amplified an ongoing YTD decline of -50.65%, and volume rose to 571,343 shares versus an average of 375,875. The price sits well below the 50‑day and 200‑day averages of CHF1.45, signalling market stress. We examine drivers, technicals, sector context and what Meyka AI’s model and grade say about short‑term risk and potential recovery.